A carregar...

CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

BACKGROUND: Research suggests that measurable change in cerebrospinal fluid (CSF) biomarkers occurs years in advance of the onset of clinical symptoms (Beckett 2010). In this review, we aimed to assess the ability of CSF tau biomarkers (t‐tau and p‐tau) and the CSF tau (t‐tau or p‐tau)/ABeta ratio t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Ritchie, Craig, Smailagic, Nadja, Noel‐Storr, Anna H, Ukoumunne, Obioha, Ladds, Emma C, Martin, Steven
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2017
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464349/
https://ncbi.nlm.nih.gov/pubmed/28328043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010803.pub2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!